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Introduction
Down syndrome is the most frequent genetic cause of mild to moderate mental retardation and 
associated medical problems and occurs in 1 out of 800 live births, in all races and economic groups. 
Down syndrome is named after John Langdon Down, the first physician to identify the syndrome in 
1866. In 1959 Lejeune, Gautier and Turpins determined that Down syndrome was caused by trisomy 
21. 1
Down syndrome and chromosomal nondysjunction occur more often in the offspring of mothers 
conceiving at an older age. Today with the focus on education, employment, career and the need to be 
financially stable before having children, late child birth is becoming the norm. Hence the incidence of 
Down syndrome is likely to increase. 
Figure 1 Down syndrome and increasing maternal age
The survival of children with Down syndrome has 
increased. More parents are now seeking care for 
these children. 2 Hence it is imperative that we 
anticipate an increase in incidence of children with 
Down syndrome and their presence at our clinics. 
Improving their quality of life and helping them to 
reach their maximum potential should be our goal. 
Children with Down syndrome are shorter than 
their peers. Average height at most ages is around 
the 2nd centile for the general population. For the majority the cause of growth retardation is not 
known. Some conditions leading to poor growth (congenital heart disease, sleep related upper airway 
obstruction, coeliac disease, thyroid hormone deficiency, deficiency of insulin like growth factor 1 and 
nutritional inadequacy caused by feeding problems) occur more frequently among those with the 
syndrome.  3, 4
Adults with Down syndrome are prone for osteoporosis. Vitamin D deficiency is known to result in 
both deficient growth and osteoporosis. There is very little data on Vitamin D levels in children with 
Down syndrome and the effect it had on growth. We wanted to see if these children had reduced 
Vitamin D levels and consequently delayed growth as correction of Vitamin D deficiency is relatively 
easy.
Surprisingly, only one study in the world has looked at the Vitamin D status in children with Down 
syndrome. That was done on a group of 21 children in Spain, 16 years ago, which did not show any 
low levels of Vitamin D metabolites in any of these children. 5 Hence there was definitely scope for 
research in this area, before any final conclusion could be made.  
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History
.                                                                                    Fig. 2: John Langdon Down
John Langdon Down was the youngest son of a 
village grocer in Cornwall. Having first 
qualified in pharmacy he entered the London 
Hospital Medical School at the age of 25 where 
he was a triple gold medalist.  He was 
appointed Medical Superintendent of the Royal 
Earlswood Asylum for Idiots in Surrey in 1856
In his definitive publication (in what he described the ethnic classification of idiots) in 1866, he wrote: 
“The very large number of congenital idiots are typical mongols. So marked is this that when placed 
side by side it is difficult to believe that the specimens compared are not children of the same parents. 
They present a close resemblance to one another in mental power”. 51
It was not until 1959 that Lejeune and colleagues discovered the extra chromosome 21 which was the 
underlying abnormality in Down's syndrome. Very little new was added to the clinical description of 
the condition apart from the description of single transverse crease in the palm noted by John Langdon 
Down's son Reginald in 1908 and the characteristic grey spots on the iris of the eye noted by Brushfield 
in 1924.51
Cytogenetic Profile
 
Trisomy is the gain of a single chromosome, 
represented as 2n +1. Approximately 94% of those 
who have Down syndrome have three full copies 
of chromosome 21, a condition termed primary 
Down syndrome.  This usually arises from random 
nondisjunction in egg formation. Most children 
with Down syndrome are born to normal parents, 
and the failure of the chromosomes to divide has 
little hereditary tendency. Fig. 3 Karyotype of a child with trisomy 
21
                     
Fig. 4 Origins of trisomy21. Rob: Robertsonian 
Fig 5 Robertsonian translocation
About 4% of people with Down 
syndrome have 46 chromosomes, but 
an extra copy of part of chromosome 
21 is attached to another chromosome 
through a translocation.  This 
condition is termed familial Down 
syndrome. It arises in offspring 
whose parents  are  carriers  of 
chromosomes  that  have  undergone  a Robertsonian translocation, most commonly between 
chromosome  21  and  chromosome  14: the  long  arm  of 21  and the  short  arm  of  14  exchange 
places. This  exchange  produces  a  chromosome  that  includes  the  long  arms  of chromosomes 
14  and  21,  and  a  very  small  chromosome  that consists  of  the  short  arms  of  chromosomes 
21  and  14. The small chromosome is generally lost after several cell divisions. About one-quarter 
of Robertsonian translocation DS is familial and three-quarters are de novo
Nondisjunction  in  a  mitotic  division  may  generate  patches  of cells  in  which  every  cell  has 
a  chromosome  abnormality  and other patches in which every cell has a normal karyotype. This 
type of nondisjunction leads to regions of tissue with different chromosome constitutions, a 
condition known as mosaicism. 6
Cytogenetic analysis of Indian children
1. In the first large Indian study, Verma et al in 1979 found that translocation karyotypes were seen in 
6.2% of children when the maternal age at conception was less than 30 years as against 1.1% when the 
maternal age was more than 30 years. Non-dysjunction was present in 92% and the rest were Mosaic.7
2. Jyothy et al studied cytogenetic data obtained from 1001 patients with Down syndrome (DS) and 
their parents over a 20 year period.  The frequency of pure trisomy, mosaicism and translocation was 
87.92, 7.69 and 4.39 per cent respectively. The origin of the extra chromosome 21 due to meiotic 
nondisjunction was 79.24 per cent maternal and 20.76 per cent paternal.8 In another study published by 
the same author, the Translocation in Down syndrome is usually of Robertsonian type with the fusion 
of chromosome 21 to D or G group chromosomes. Most frequent forms are t (21; 21) and t (14; 21). 
The other less frequent translocations are t (13; 21), t (15; 21) and t (21; 22). 9
3. Sheth et al looked at 382 clinically suspected children with Down syndrome. Free trisomy 21 
constituted 84.8% of cases, translocation 8.9%, mosaic 3.9% and in 2.4% cases regular T21 was 
associated with structural or numerical changes. Translocation was parentally inherited in 26.5% cases 
and maternal transmission was twice as common as paternal. Males were more pronounced to be 
affected than females in all the groups. 91.6% of DS babies were born to younger mothers (20-35 yr) 
compared to 8.4% in elderly mothers (>35 yr). 10
4. Kava et al studied 524 patients with Down syndrome over a period of 7.5 years.  Results of 
cytogenetic abnormalities were available in 42.2%. Free trisomy (non-dysjunction) was present in 95%, 
3.2% had translocation, and 1.8% were mosaics. 11
Growth and Growth Charts
Short stature is characteristic of Down syndrome. 
• Growth retardation commences prenatally
• After birth, growth velocity is most reduced between 6 months and 3 years of age
• Puberty generally occurs early and is associated with an impaired growth spurt
• These individuals reach their final height at relatively young ages. 12
There is also a predisposition to overweight, particularly among adolescents and adults that may itself 
be related to the growth deficiency since it reduces energy requirements. In addition to being a risk 
factor for metabolic disorders, overweight is an aggravating factor for other conditions that affect this 
group, such as heart diseases and muscular hypotonia.13
Although growth is influenced by biological and environmental factors, racial variations certainly have 
a major role. For the majority, the cause of growth retardation is not known. Some conditions 
postulated to lead to poor growth are: 
• congenital heart disease
• sleep related upper airway obstruction
• coeliac disease
• thyroid hormone deficiency
• deficiency of insulin like growth factor 1 
• nutritional inadequacy caused by feeding problems. 3,4 
Growth Charts
Statural growth is a well known indicator of health during childhood. As growth and final height differ 
markedly between children with Down syndrome and healthy children, standard growth charts should 
not be used for children with Down syndrome. 
The publication of growth charts specifically for children with Down syndrome in various populations, 
e.g. American, Sicilian, Dutch and French draws attention to the importance of constructing growth 
charts for Indian Down syndrome children.
The potential benefits of growth charts include: 
• growth monitoring to detect any deviation in growth patterns
• evaluating the efficacy of measures aimed at promoting growth
• providing reassurance to parents
• evaluating the results of clinical research or intervention for individual patients 
• comparing their growth with that of the normal population
• detection of the development of an additional disease which impairs growth such as 
hypothyroidism or coeliac disease. 12, 14
Percentile distributions of anthropometric indexes - weight-for-age (W/A) and height-for-age (H/A) 
specific for children and adolescents with DS have been developed. The distribution compiled in the 
United States by Cronk et al is one of the most often cited in the literature and has distributions for 
weight according to sex and covering the age group from 1 month to 18 years. Other charts have been 
developed in Spain, Sweden, the United Kingdom and Ireland, Italy, Saudi Arabia, Brazil and Japan. 13
1. Lopes et al 13 plotted height and weight of 138 children with Down syndrome on 3 growth charts 
(Cronk Charts, USA; Spanish charts for children with Down syndrome and the WHO charts for normal 
children). As can be seen from the following table, there was wide variation in the number of children 
categorized into the different categories (< 5th centile and >95th centile for height and weight) by 
different charts. There was poor agreement among the three charts. They emphasized the need for 
region specific growth charts for children with Down syndrome. They also summarized the findings 
from various studies around the world which is given below.
Table 1 Weight for age and height for age indexes of children and adolescents with Down syndrome 
classified according to three different reference distributions
Myrelid et al. also compared anthropometric data from Swedish children and adolescents with Down 
syndrome with the Down syndrome -specific distribution from the United States. The mean height of 
the Swedish Down syndrome subjects at 18 years of age was greater than that of the individuals with 
Down syndrome from the United States. In terms of weight, the mean weight of the Swedish 
adolescents with Down syndrome at 18 years corresponded to the 50th percentile for boys and the 25th 
percentile for girls on the distribution from the United States. The authors attributed these differences 
to ethnic diversity and the different sample sizes.
In Portugal, Fernandes et al. examined 196 children aged 0 to 48 months with DS and 96 siblings of 
these children who did not have DS. When they compared their results with the DS-specific 
distribution from the United States, the authors observed that the Portuguese children had a similar 
growth to those in the United States up to 24 months of age, but, from 24 to 48 months, they exhibited 
higher values for length and weight.
In a study carried out in Chile, Pinheiro et al. conducted research with 116 children and adolescents 
with DS, aged from 3 months to 18 years. These authors assess agreement between diagnoses of W/A 
and H/A indexes according to the DS-specific distributions from the United States and Spain. 13 
2. In India, Sachdev et al 15 in 1981 measured anthropometric indices of 139 children up to the age of 5 
years. They found that the height curves in the first 9 months fell below the 50th percentile of normal 
children and subsequently there was a marked fall below the 10th centile.  The weight curve fell slightly 
below the tenth centile and advanced almost parallel to it. Head circumference measurements were 
similar. Time taken to reach “normal height and weight” was between one and a half to two times for 
children with Down syndrome. However since then, there have been no further studies, especially for 
older children. 
Vitamin D levels, Bone density
Vitamin D status has a profound effect on growth and development of children and has major 
implications for adult bone health. Overt cases of vitamin D deficiency represent only the tip of an 
iceberg of vitamin D insufficiency. Severe vitamin D deficiency is usually associated with 25-
hydroxyvitamin D [25(OH) D] concentrations less than 5.0 ng/mL and results in rickets and 
osteomalacia. Less severe deficiency has been associated with numerous negative skeletal 
consequences, including secondary hyperparathyroidism, increased bone turn over, enhanced bone loss 
and fracture risk. 
In assessing a person’s vitamin D status the most commonly used and most sensitive index is 25(OH) 
D.   1, 25-dihydroxyvitamin D [1, 25(OH) 2D] can be normal, high, or low in vitamin D deficiency. 
Age, sex, pubertal status, latitude, season, race, and ethnicity influence serum concentrations of 25(OH) 
D. Unfortunately, assays for 25(OH) D still lack sufficient standardization as indicated by international 
comparative studies.  The assays are not cross calibrated and differences of upto 38% have been 
reported in 25(OH) D estimations across different laboratories. Hence, serum 25(OH) D levels from 
different regions or countries cannot be compared satisfactorily.
Children with Down syndrome are shorter than their peers. The cause for this is unclear. Adults with 
Down syndrome are prone for osteoporosis. Vitamin D deficiency is known to result in both deficient 
growth and osteoporosis. There is very little data on Vitamin D levels in children with Down syndrome 
and the effect it had on growth. 
1.  Del Arco et al 5 in 1992 published their findings from 21 children with Down syndrome in 
Cantabria, Spain.  The serum levels of the active Vitamin D metabolites 25-hydroxyvitamin D [25(OH) 
D], 1, 25-dihydroxyvitamin D [1, 25(OH) 2D] and 24, 25 dihydroxyvitamin D [24, 25(OH) 2D]) were 
checked. Serum calcium, magnesium, phosphate, alkaline phosphatase, parathormone and osteocalcine 
were also determined. 
In the Down syndrome group, the average values of the three Vitamin D metabolites were comparable 
to those of an age-matched group both in winter and summer. No child with Down syndrome showed 
values below the normal range, either in Vitamin D metabolites, or in the other parameters of calcium 
metabolism. This investigation showed that children with d Down syndrome do not require Vitamin D 
prescription when appropriate periods of sunlight exposure are provided.
2. The bone mineral density (BMD) of lumbar vertebrae of children with Down syndrome was studied 
by Kao. 17 The BMD was measured by dual photon absorptiometry (DPA). They showed that the BMD 
in Down's syndrome was significantly lower compared to that found in normal children (P < 0.01).
Hence we thought that there was need to see if children with Down syndrome had deficiency of 
Vitamin D. However the definition of hypovitaminosis D is not standardized. Different authors have 
used different cut off levels. Below are some of the significant Indian studies – some in normal children 
and some in adults. 
1. Marwaha et al 18 studied a cohort of 5137 children and adolescents to assess the prevalence of 
vitamin D deficiency. They found clinical evidence of vitamin D deficiency in 556 children (10.8%). 
They compared biochemical variables (in 760 children) of the calcium–vitamin D axis between 2 
socioeconomic groups and studied the effect of hypovitaminosis D on bone mineral density. 
Concentrations of 25(OH) Vitamin D of 10–20, 5–10, and less than 5 ng/mL were classified as mild, 
moderate, and severe hypovitaminosis D as recommended by Lips.
The unadjusted mean serum concentration of 25(OH) D for the entire group was 11.8 +/_7.2 ng/mL. 
Adjusted mean +/_ SE values of serum 25(OH) D for the lower socioeconomic score group was 10.4+/ 
_ 0.4 and 13.7 +/_ 0.4 ng/mL for the upper socioeconomic group (p <0.01).  Age, sex, and SES 
independently influenced the variations in 25(OH) D concentrations.
Males had significantly higher mean serum concentrations than did females (P<0.004). According to 
the Lips classification, hypovitaminosis D was seen in 92.6% of the LSES group (severe: 11.2%; 
moderate: 39.5%; and mild: 42.1%) and in 84.9% of the USES group (severe: 4.9%; moderate: 25.5%; 
and mild: 57.6%).  Thus severe hypovitaminosis D (<5 ng/mL) was seen in 8.6% of their study 
population.
Severe hypovitaminosis D (<5 ng/mL) was seen in 8.6% of their study population, in 23.5% of Finnish 
adolescents, and in 45.2% of Chinese adolescents in and 6.7% in summer. In other studies from 
Finland, using cutoffs of 8–10 ng/mL, the prevalence of hypovitaminosis D was 13.5%, which 
compares with 37% of children in the current study who had serum 25(OH)D concentrations <9ng/mL 
(lower limit of manufacturer’s normal range).
Other studies have also noted low serum 25(OH) D concentrations among adults of Indian origin in 
both India and the United Kingdom. This value was significantly lower than that reported in studies 
from Europe and Brazil and marginally higher than that reported from China.
2.  Pettifor in an editorial in Indian Pediatrics said:  “The use of varying cut off points for vitamin D 
deficiency and insufficiency by different authors has made it difficult to compare the results of research 
published by different authors and has further complicated comparisons between different communities 
and populations.”. He recommended a cut off value of 10 ng/ml to define vitamin D deficiency.19
3. Sharma et al from the All India Institute of Medical Sciences defined hypocalcemia in children as 
total serum concentration levels less than 8.0 mg/dl with normal concentrations of serum albumin. 
They identified 29 patients over an 11 year period. 20
4.  Hypophosphatemia was assessed based on the different cut off points for different age groups. (1-3 
yr 3.8-6.5mg/dl; 4-11yr 3.7-5.6mg/dl; 12-15yr 2.9-5.4mg/dl). 21
5. Alkaline phosphatase levels considered normal were based on the different cut off points for 
different age groups (1-9 yrs: 145-420U/L; 10-11 years 130-560U/L ; 12-13 years Male 200-495U/L; 
Female 105-420 U/L;  14-15 years Male: 130-525 U/L; Female 70-230 U/L). 21
Bone Age
"Bone age" of a child is the average age at which children reach a particular stage of bone maturation. 
At birth, only the metaphyses of the long bones are present. As a child grows the epiphyses become 
calcified and appear on the x-rays, as do the carpal and tarsal bones of the hands and feet. As sex 
steroid levels rise during puberty, bone maturation accelerates. The cartilaginous zones become 
obliterated and the epiphyses are said to be closed.
The most commonly used method is based on a single x-ray of the fingers, hand, and wrist. A hand is 
easily x-rayed with minimal radiation and shows many bones in a single view. The bones in the x-ray 
are compared to the Greulich and Pyle standard.
The Brush Foundation enrolled 1000 children from 1931 to 1942. They were examined at regular 
intervals and different anthropometric measurements, X-ray films, psychometric and psychological 
tests were administered. Based on this the Greulich and Pyle Atlas of skeletal maturation of the hand 
was published. 22 
They looked for a method which would provide more precise data about the development of the child 
than could be inferred from its height, weight and age alone. People belonging to different ethnic 
societies had different heights and weights at the same age and so a single height/weight for age chart, 
could not be used for all children. Children of different regions have different age of onset of puberty. 
Thus the age at which the maximum annual increment of height and weight occurs – the so called 
preadolescent spurt of growth, is different in different people groups. They thus looked for a 
dependable indicator of maturity, which would be independent of body size. The development status of 
the skeleton as disclosed by an X-ray film of the hand and wrist appeared to meet this need.
Phenotypic profile, Associations and Natural history: an Overview
The following abnormalities are seen in Down syndrome 23
General: Hypotonia, hyperflexibility of joints, relative short stature with an awkward gait.
Central Nervous System: Mental deficiency
Craniofacial: 
• Brachycephaly with a relative flat occiput and a tendency toward midline parietal hair whorl
• Mild microcephaly with upslanting palpebral fissures
• Thin cranium with late closure of fontanelles
• Hypoplasia to aplasia of frontal sinuses, short hard palate
• Small nose with low nasal bridge
• A tendency to have inner epicanthal folds.
Eyes: Speckling of iris (Brushfield’s spots) with peripheral hypoplasia of iris; fine lens opacities by slit 
lamp examination (59%); refractive error.
Ears: Small; overfolding of angulated upper helix; sometimes prominent; small or absent ear lobes.
Dentition: Hypoplasia, irregular placement, fewer caries than normal.
Neck: Appears short.
Hands: 
• Relatively short metacarpals and phalanges. 
• Fifth finger: Hypoplasia of midphalanx of fifth finger (60%) with clinodactyly(50%), a single crease 
(40%), or both
• Simian crease (45%).
• Distal position of palmar axial triradius(84%)
• Ulnar loop dermal ridge pattern on all digits (35%)
Feet:  Wide gap between first and second toes; plantar crease between first and second tos. Open field 
dermal ridge pattern in hallucal area of sole (50%).
Pelvis: Hypoplasia with outward lateral flare of iliac wings and shallow acetabular angle.
Cardiac: Anomaly in about 40%; atrioventricularis communis, ventricular septal defect, ASD and aberrant 
subclavian artery in descending order of frequency.
Skin: Loose folds in posterior neck (infancy). Cutis marmorata, especially in the extremities (43%).Dry 
hyperkeratotic skin with time (75%).
Hair: Fine, soft and often sparce; straight pubic hair at adolescence
Genitalia: Male: relatively small penis. Hypogonadism in terms of fertility (100%) and testosterone 
production.
Other abnormalities: Seizures (<5%), Strabismus (33%), Nystagmus (15%), keratoconus (6%), cataract 
(1.3%), low placement of ears; webbed neck; tracheoesophageal fistula, duodenal atresia, tetralogy of 
Fallot; atlantoaxial dislocation(12%),cryptorchidism (27% till 9 years and 14% after 15 years), syndactyly 
of second and third toes. The incidence of leukemia is about 1:95, or close to 1%. Thyroid disorders are 
common.
Down Syndrome and Heart Disease
Approximately 40% of children with Down syndrome have congenital heart disease. The Atlanta Down 
Syndrome Project evaluated 227 children with trisomy 21 with Congenital Heart Disease (CHD):
• 45% had an atrioventricular septal defect (AVSD; with or without other CHD)
• 35% had a ventricular septal defect (VSD; with or without other CHD)
• 8% had an isolated secundum atrial septal defect
• 7% had an isolated persistent patent ductus arteriosus
• 4% had an isolated tetralogy of Fallot
• 1% had other defects. 52
Similar studies have shown comparable statistics. Left sided obstructive lesions such as coarctation and 
valvar aortic stenosis are rare, and transposition of the great arteries has not been reported in Down 
syndrome. All babies with Down syndrome should have an early screening echocardiogram.
Bhatia et al evaluated the utility of echocardiography in assessing the frequency and nature of cardiac 
malformations in children with Down syndrome. Fifty cases of chromosomally proven Down 
syndrome were studied. Twenty-two (44%) children had heart diseases.
 Endocardial-cushion-defect was the commonest anomaly, followed by ventricular septal defect.  The 
study further suggests that clinical examination of the cardiovascular system alone may not be 
sufficient in detecting heart disease. Two-dimensional echocardiography offers an excellent non-
invasive tool for diagnosing cardiac malformations in Down syndrome. 24
Thyroid Disorders
Down syndrome is one of the most common causes of mental retardation. Hypothyroidism might be 
one reason for growth retardation in Down syndrome. The reported prevalence of hypothyroidism has 
varied between 3% and 54%.  Thyroid autoantibodies are found in 13-34% of patients. Thus, both 
hypothyroidism and hyperthyroidism are more common in patients with Down syndrome than in the 
general population 25
1. Gibson et al did a longitudinal study on thyroid disease in Down syndrome. The following 
definitions were used: 
• Hypothyroidism: low thyroxine and TSH of 6 mu/ml  or more
• Isolated raised TSH (IR-TSH): normal thyroxine and TSH  of 6 mu/ml or more
• Euthyroid: normal thyroxine and TSH less than 6mu/ml
• Positive auto antibodies: titre greater than 1:64
81% had normal thyroid function and 19% had IR-TSH. Between the first sampling and the resampling 
about 5 years later, 18 out of 122 children were lost to follow up. Of the 103 individuals resampled, 
92% had normal thyroid function, 9.7% had IR-TSH and two cases (2%) of definite hypothyroidism 
were identified. The cause of IR TSH was not determined. Autoantibodies were seen in nine at first 
testing and in seven at second testing. On both occasions a positive association was seen with IR-TSH 
but not with hypothyroidism. 26
2. Tuysuz et al studied 320 children with Down syndrome between 5 days to 10 years. They concluded 
that the prevalence of congenital hypothyroidism was 1.8% in children with Down syndrome while 
25.3% of them had compensated hypothyroidism. Besides congenital hypothyroidism cases, those with 
TSH levels between 11 and 20 mU/l may benefit from treatment with low-dose thyroxine. 27
3. Unachak et al studied 140 patients aged from 3 days to 14 years. 
• Ten patients (7.1%) were diagnosed with overt thyroid disease: congenital hypothyroidism 
3.6%, acquired hypothyroidism associated autoimmune thyroiditis 1.4% and hyperthyroidism 
2.1%. 
• Sub-clinical hypothyroidism (SH) accounted for 32.9% of all cases; 10.7% showed a 
spontaneous decrease to normal TSH levels and 13.6% had persistently elevated TSH levels 
with the median follow-up time of 6 and 12 months, respectively. 28
4. Sharav et al showed that 60% had a TSH level higher than 5.7 mU/L in the presence of high or 
normal thyroxine levels.  High TSH levels were predominant in patients under 4 years of age, ie, during 
the phase of active growth, and showed a declining trend with increasing age. All of these infants had 
delayed growth of all parameters including head circumference, height, and weight, as compared with 
normal infants, and growth was particularly retarded in patients with TSH levels greater than 5.7 mU/L. 
29
5.  Karlsson et al studied 85 patients with Down syndrome in a longitudinal study between the ages of 1 
year and 25 years. Two patients had thyrotoxicosis associated with high concentrations of TSH receptor 
stimulating antibodies. This agrees with earlier reports that Down syndrome children also run higher 
risks of thyroid hyper function compared with healthy subjects. 25
Haematological Malignancies
A cohort of 120 children with Down syndrome with acute lymphoblastic leukaemia (ALL) were 
studied and treated at AIEOP centers in Italy between 1982 and 2004. 30 Ten-year event-free survival 
and survival were significantly worse compared with non-DS patients (P < 0.001). DS patients 
diagnosed since 1995 had a better outcome (P = .06) than those diagnosed in previous years, but still 
had worse outcomes than non-DS patients (P = .04). Event-free survival of DS patients at NCI standard 
risk was lower than that of non-DS patients (P = .006).
Presenting features of childhood ALL in DS differ from those in non-DS patients. Girls are more 
commonly affected. There were no affected infants and the immunophenotype (T-lineage exceptionally 
rare). Furthermore, TEL/AML1 accounts for about 20% of childhood ALL in most series worldwide but 
in their series only 1 case was positive. They are almost invariably characterized by BCP phenotype, 
and are often TEL/AML1 negative. Treatment of acute leukemia in DS subjects are apparently more 
favorable in AML, but not in ALL. The unfavorable outcome could be attributed to the biology of the 
disease, to the DS host characteristics, or to the treatment applied. 
Pui et al noted in 1993 that children with DS and ALL had a low frequency of adverse clinicobiologic 
features at diagnosis; however, these findings did not translate into a better outcome, apparently 
because of treatment-related toxicity. 
The definition of anaemia used for analysis was haemoglobin in the age group 6mth-6yrs haemoglobin 
is <10.5 gm/dl; 7yr-12yr <11 gm/dl, 12-18 yrs: female <12 gm/dl and male <13 gm/dl.21 
Otolaryngologic Manifestations of Down Syndrome
Common anamolies of the ear, nose and throat associated with Down syndrome are: 53
• Orofacial: Progressive enlargement of lips with age, macroglossia, high narrow palatal vault, 
delayed dental age and hypoplastic middle third of the face
• Upper airway and special considerations: small nasopharyngx and oropharynx, mild to 
moderate subglottic narrowing and obstructive sleep apnea syndrome
• Otologic Disorders: Pinna size is small. Diameter of the external auditory canal is also 
significantly decreased. 
• Conductive hearing loss in Down syndrome is also caused by middle ear disease particularly 
otitis media. Conductive hearing loss can also be due to ossicular fixation or residual 
mesenchymal tissue in the middle ear.
• Sensorineural hearing loss. A study has revealed progressive ossification along the outflow 
pathway of the basal spiral tract that leads to the cochlear nerve. 
• Other studies have demonstrated temporal bone anomalies: mondini’s cochlea, shortened apical 
cortical turns, shortened organ of corti, decreased spiral ganglion cells, widened semicircular 
canals and vestibules, anomalous lateral semicircular canals and vestibules and residual middle 
ear mesenchyme.
Ophthalmological manifestations in Down syndrome
Proper ophthalmologic evaluation is necessary in children with Down syndrome as it influences their 
educational development. 
da Cunha et al studied a total of 152 children with Down's syndrome between two months and 18 years 
of age. 31
• Ocular findings in decreasing prevalence were the following:  upward slanting of the palpebral 
fissure with the outer canthus 2 mm or higher than the inner canthus (82%), epicanthal folds 
(61%), astigmatism (60%), iris abnormalities (52%), strabismus (38%), lacrimal system 
obstruction (30%), blepharitis (30%), retinal abnormalities (28%), hyperopia (26%), amblyopia 
(26%), nystagmus (18%), cataract (13%), and myopia (13%). 
• Patients younger than five years had a higher prevalence of hyperopia than those in other age 
groups; patients between five and 12 years old had a higher prevalence of astigmatism; and 
patients older than 12 years of age had more iris abnormalities, strabismus, and cataract. 
Myopia and myopic astigmatism were more common in the patients with cardiac 
malformations. 
Gonzalez et al examined 60 children with Down syndrome and 60 controls. Children with Down 
syndrome had a significantly higher incidence of refraction errors as a whole (p 0.001), myopia (p 
0.01), hypermetropia (p 0.02), astigmatism (p 0.001) and strabismus (p 0.001). 32
Atlantoaxial dislocation
Cervical spine instability associated with Down syndrome has been of concern since it was first 
reported by Spitzer in1961. Between 10% and 30% of individuals with Down syndrome show 
radiographic evidence of an increased atlanto dens interval (ADI).  Determination of the ADI provides 
indirect information about the space available for the cord (SAC). 
Pueschel et al reported that 14.6% of 404 patients with Down syndrome had an ADI greater than 
4.5mm, but only 1.5% of the group had symptoms and were ultimately treated with surgical 
stabilization of the cervical spine. Increased ADI in the Down syndrome population has not been 
directly correlated with a concomitant increase in neurologic compromise.
Radiographs of the cervical spine in the Down syndrome population must be evaluated by standards 
specific to that population and not by traditional standards derived from radiographs of the cervical 
spine in the general population. 
MRI may be helpful in determining the presence of cord compression in flexion and is most significant 
when signal changes exist within the cord. When the anterior aspect of the cervical spinal cord is 
compressed by the odontoid process during flexion of the neck, impending myelopathy is of concern. 
Progressive rotary subluxation of the atlantoaxial junction will significantly narrow the spinal canal and 
may impose marked, irreversible cord injury. Somatosensory evoked potentials have been used to 
detect cord compromise in patients with Down syndrome who show abnormal radiographic findings of 
the cervical spine but are clinically asymptomatic. 33
                                    Down syndrome and social quotient
Bhatia et al 34 studied 40 consecutive children with Down syndrome. Developmental Quotient (DQ) of 
children in the study group was evaluated by a clinical psychologist  using Gessel’s developmental 
schedule, Seguin Form Board, Vineland social maturity scale, DASSI-II (Bayley’s scale), Malin’s 
Intelligence Scale (for Indian children) and Stanford-Binet test. 50% had Developmental Quotient of 
51-70 followed by 32.5% with DQ 36-50, 10.0% with DQ 30-35 and 7.5% with DQ above 70.
Various studies have shown that children with Down’s syndrome showed low scores on motor, 
adaptive and social development at all ages as compared to normal children. This is also seen in 
relation to feeding, socialization, toilet training and sleep. 34
The Vineland Social Maturity Scale measures the different social capacities of an individual. It 
provides an estimate of social age (SA) and social quotient (SQ) and shows a high correlation (0.8) 
with intelligence. It is designed to measure social maturation in eight social areas: Self help general, 
self help eating, self help dressing, self direction, occupation, communication, locomotion and 
socialisation. The scale consists of 89 test items grouped into year levels. It can be administered to 
children between the age groups of 0 – 15 years. Social quotient = 100 X (social age in 
months/chronological age in months) 35
Aims
The main aims of the study were:
1. To study the prevalence of Vitamin D deficiency by assessing 25(OH) Vitamin D levels in 
children with Down syndrome.
2. To assess the effect of 25(OH) Vitamin D deficiency on height, bone age and other biochemical 
markers in these children. 
Since there were very few recent clinical studies published on children with Down syndrome in India, 
we also aimed to look at
1. Assessment of the phenotypic and cytogenetic profile of Children with Down syndrome and 
presence of common associated malformations, deficiencies and associated illnesses.
2.  An evaluation of their social quotient.
Materials and Methods
Study setting: The study was conducted in the Department of Child Health, Christian Medical College, 
Vellore – a tertiary care medical centre in South India.
Study Period: The duration of the study was from October 2007 to September 2008. 
Study Design: Prospective descriptive study
Instuments: Questionnaire
Inclusion Criteria:  Children clinically suspected to have Down syndrome between the ages of 5 
months- 16 years and who were cytogenetically proven were enrolled in the study. 
• Informed consent was obtained from the parents.
• Relevant history and detailed clinical examination was carried out. 
• Measurements were taken by the Primary investigator or trained nurses. Height was measured 
on the infantometer in those less than 2 years or those who could not stand. In older children the 
stadiometer was used. Weight was checked on a sensitive electronic weighing scale to the 
closest 10 grams. The head circumference was measured using non stretchable tapes to the 
nearest millimeter taking the maximum occipitofrontal diameter.   
• The height and weight (and head circumference for children less than 3 years) were plotted on 2 
growth charts – growth charts of “normal” Indian children (Agarwal) as recommended by the 
Expert group of the Indian Academy of Pediatricians 36 and growth charts for children with 
Down syndrome as described by Cronk. 37
• Blood was collected for the following investigations: complete blood count, thyroid function 
test and thyroid stimulating hormone, calcium, phosphorus, alkaline phosphatase, 25(OH) 
Vitamin D levels (by Automated Chemiluminescent Immunoassay) and karyotyping (Annexure 
1)
• X-ray left hand and wrist was taken for bone age and lateral neck X-ray in neutral position to 
look for atlanto-axial dislocation in children older than 3 years. Echocardiogram, eye checkup 
and hearing assessment were done. Developmental assessment (social quotient) was done using 
the Vineland Social Maturity Scale.
• The data was entered in a spreadsheet and analyzed by SPSS software version 11.
The following definitions were used in our study: 
1. Hypertelorism: Canthal index: Inner canthal distance/outer canthal distance X 100
It is normally 38 in males, 38.5 in females. It is increased in hypertelorism. 38
2. Upslanting eyes: upward slanting of the palpebral fissure with the outer canthus 2mm or 
higher than the inner canthus 31
3. Epicanthal folds: An epicanthal fold is skin of the upper eyelid -- from the nose to the inner 
side of the eyebrow -- that covers the inner corner (canthus) of the eye.
4. Prominent malformed ears: Abnormal helix, low set ears
5. Clinodactyly: Short incurved fifth finger because of hypoplasia of mid phalanx of fifth 
finger. 38
6. Sandal gap: Wide gap between the first toe and the second toe. 38
Results – an Overview
• Demography
• Cytogenetic profile of children with Down
• Maternal history
• Anthropometry
• 25 (OH) Vitamin D levels; calcium, phosphorus and alkaline phosphatase
• Bone age
• Phenotypic profile
• Heart disease
• Thyroid 
• Hematology
• Atlantoaxial dislocation
• Ophthalmology and Hearing  
• Social quotient
• Socioeconomic status
Demography
Sixty two children suspected to have Down syndrome were interviewed. Six were excluded:
• two had cytogenetic profile of Down syndrome but were not willing for further tests
• three had clinical features of Down syndrome but did not give blood for further testing and 
confirmation
• The sixth child’s cytogenetic analysis did not show Down syndrome 
Thus, 56 children - 42 boys (75%), and 14 girls (25%) were included in the analysis. The table and 
graph below describe the age and sex distribution of the children. 
Table 2 Overview of age of the children included in the study
Mean age 4.33 years
Median age 2.87 years
Standard deviation 4.03
Minimum age 5 months
Maximum age 14.9 years
     
 Figure 6 Age and sex distribution of the children included in the study
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The commonest age group was 1 – 3 years, followed by 3-6 years. Boys outnumbered girls 3:1.
Cytogenetic Profile
All children included in the study had cytogenetic confirmation of Down syndrome. The frequency of 
the different Cytogenetic abnormalities is given in the table below. Since the association between the 
Cytogenetic abnormalities and the social quotient has not been looked at before, we also analysed this 
separately.
Table 3 Cytogenetic profile of the children included in the study
Cytogenetic analysis Frequency Percentage
Trisomy 21 50 89.3
Translocation 4 7.1
Mosaic 2 3.6
Total 56 100
Translocation
3 children in the study had t (21; 21) translocation and one had t (14; 21)
• 46XXder (21,21) (q10,10)+21[20] Robertsonian translocation
• 46 XXder (14;21)(q10:q10) +21, trisomy due to Robertsonian translocation (14,21),
• 46XY t(21.21), DS along with homologous Robertsonian translocation
• 46XYder(21,21)(q10,q10)+21[20])
Mosaicism
Of the 2 mosaic children, 
• one had 47XY+21 (13) 46 XY (7) and 
• the other had 47XY+21 (17) 46 XY (3).
We analysed the cytogenetic findings with the various other aspects of our study. A synopis of our 
findings is given below. In view of the small numbers, the significance is not clear.
• Boys constituted 76% of the trisomy (38/50), 50 % of the translocations (2/4) and 100% of the 
mosaics (2/2).
• All 3 patients with atlantoaxial dislocation had trisomy 21.
• Of the 3 patients who had acute lymphoblastic leukaemia, 2 had trisomy (4% of the trisomy) 
and one had translocation (25% of the translocations).
• Of the 10 children whose parents had consanguineous marriage, 8 had trisomy and one each had 
translocation and mosaic.
• On the Cronk charts for weight, 50% of the translocations (2/4) and 100 % of the mosaics (2/2) 
had weight above the 50th centile, while only 24% of the children with trisomy (12/50) were 
above the 50th centile. This was not statistically significant. 
• There was no statistical significance or trend between the different cytogenetic abnormalities 
and the other anthropometric measurements (height, weight and head circumference) as 
checked on both the charts
• Of the children who were evaluated for hearing abnormalities, 49% of the children with trisomy 
(17/35), 75% of those with translocation (3/4) and 100% of the mosaics (1/1) had hearing 
abnormalities.
• There was no significant relationship between the cytogenetic abnormalities and cardiac 
abnormalities, bone age and ophthalmological abnormalities.
Maternal History
Maternal age at delivery
Figure 7 Maternal age at delivery categorized in groups
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35.4% of the mothers were older than 30 years with 10.9% older than 35 years.
Figure 8 Maternal age at delivery of children with Down syndrome
The mean maternal age at the time of delivery was 27 years. 
Figure 9 Birth rank of children grouped according to the sex of the children
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23 of the children were the first born, 28 were second/ third born, and 4 children were of the 
birth rank 4 or greater. 1 child was adopted and details were not known.
• Five (9.1%) of the mothers had previous spontaneous abortions.
• The mean age of the maternal grandmother at time of mother’s birth was 24 years. 
However some of the parents were not sure about the exact age.
• 8 of the 55 children (15%) had consanguineously married grand parents. 1 child was 
excluded as he was adopted.
• 10 of 55 children (18%) had consanguineously married parents
• The mean birth weight of the children was 2.5kg. The minimum weight was 1.4kg and 
the maximum weight was 3.92kg.
• Antenatal scan was done in 39 (69.6%) of the 55 children. In none of the scans were 
features of Down syndrome picked up. None of the mothers underwent any screening 
for Down syndrome. None of them knew antenatally that their child had Down 
syndrome.
Anthropometric Measurements
Figure 10 Distribution of height on the 
IAP growth charts
Height in Centiles
>=5025 - 503 - 25<3
Nu
mb
er
40
35
30
25
20
15
10
5
0
Figure 11 Distribution of height on the Cronk 
growth charts
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On the IAP charts, the distribution was as follows: 62.5% <3rd centile, 21.4% between 3rd -25th 
centile, 12.5% between 25th - 50th centile and 3.6% >= 50th centile. 
On the Cronk charts, the distribution was as follows: 7.1% <5th centile, 21.4% between 5th -25th 
centile, 30.4% between 25th - 50th centile and 41.4% >= 50th centile.  
Thus, there is hardly any correlation between the two charts.
Height Vs Age
The children were clubbed into 2 groups based on their age (< 3years and >=3 years). There 
was no statistical difference between the children in the two age groups with relation to their 
height – (IAP and Cronk charts). There was no statistical difference between the two sexes on 
comparison of the height of the children either by the IAP or the Cronk chart.
Figure 12 Distribution of weight on the IAP 
growth charts
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Figure 13 Distribution of weight on the 
Cronk growth chart
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On the IAP charts, the distribution of weight was: 50% <3rd centile, 23.2% between 3rd -25th centile, 
8.9% between 25th - 50th centile and 17.9% >= 50th centile.
On the Cronk charts, the distribution of weight was: 17.9% <5th centile, 28.6% between 5th -25th 
centile, 25% between 25th - 50th centile and 28.6% >= 50th centile.
Weight Vs Age
Table 4 Weight according to the IAP growth chart vs. age
Count
26 3 29
15 12 27
41 15 56
< 3
>=3
AGE IN
YEARS
Total
<25 >=25
IAP weight Centiles
Total
There was no difference between the age groups when the Cronk charts were used to plot 
weight. However, when the IAP chart was used, it was found that 90% of the children less than 
3 years were below the 25th percentile as opposed to 56% of those above three years. This was 
statistically significant (p 0.004). Thus children with Down syndrome appear to increase their 
weight with age.
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Figure 14 Weight as per the Figure 15 Weight as per the Cronk
 IAP chart vs. sex of the child chart vs. sex of the child
As seen in the two figures above, when the weight was plotted on the two charts, it was seen 
that a higher percentage of girls were above the 25th percentile as compared to the boys. This 
was statistically significant in the Cronk chart (p<0.05), though this has to be interpreted with 
caution as one third of the cells had an expected value less than 5.
Figure 16 Prevalence of the children with microcephaly.
The head circumference was plotted on IAP 
growth charts for children less than 3 years. 
86% of them were microcephalic (head 
circumference <3rd centile). There was no 
difference between the two sexes.
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25(OH) Vitamin D levels
Pettifor in an editorial in Indian Pediatrics had stated “The use of varying definitions for vitamin D 
deficiency has made it difficult to compare the results of research by different authors and has further 
complicated comparisons between different communities and populations.” He recommended that 
vitamin D deficiency should be defined as 25(OH) D values <10 ng/mL. 19
Figure 17 Distribution of serum 25 (OH) Vitamin D levels
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The mean serum 25(OH) vitamin D level in the study population was 16ng/ml.
Figure 18 Prevalence of 25 (OH) Vitamin D deficiency (<10ng/ml)
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The prevalence of 25(OH) vitamin D level <10ng/ml was 26.8% and >=10ng/ml was 73.2%.
Figure 19 Prevalence of 25(OH) Vitamin D < 10 ng/ml in the different age groups.
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25(OH) Vitamin D deficiency was more in  children less than 3 years  (p 0.051).  This is  probably 
because of low exposure to sunlight in this age group.
Table 5. 25(OH) Vitamin D levels vs. sex of the child (p 0.6)
Count
12 3 15
30 11 41
42 14 56
< 10 ng/ml
>= 10 ng/ml
25 (OH) Vitamin D
Total
Boy Girl
Sex
Total
Table 6. 25(OH) Vitamin D levels vs. height as plotted on IAP chart (p 0.75)
Count
9 5 1 15
26 14 1 41
35 19 2 56
< 10 ng/ml
>=10 ng/ml
25 (OH) Vitamin D
Total
< 3 rd
centile
3 - 50 th
centile
>= 50th
centile
Height as per IAP charts
Total
Table 7. 25(OH) Vitamin D levels vs. height as plotted on Cronk chart (p 0.26)
 Count
10 5 15
4 19 18 41
4 29 23 56
< 10 ng/ml
>=10 ng/ml
25 (OH)
Vitamin D
Total
<5th
centile
5th to 50th
centile
>=50th
centile
Height as per Cronk Chart
Total
Table 8. 25(OH) Vitamin D levels vs. weight as plotted on IAP chart (p 0.95)
 
Count
7 5 3 15
21 13 7 41
28 18 10 56
< 10 ng/ml
>=10 ng/ml
25 (OH) Vitamin D
Total
< 3rd
centile
3 - 50th
centile
> 50th
centile
Weight as per IAP chart
Total
Table 9. 25(OH) Vit D levels vs. weight as plotted on the Cronk chart (p 0.41)
 
Count
1 9 5 15
9 21 11 41
10 30 16 56
< 10 ng/ml
>=10ng/ml
25 (OH) Vitamin D
Total
< 5th
centile
5th - 50th
centile
>= 50th
centile
Weight as per Cronk chart
Total
Table 10. 25(OH) Vitamin D levels vs. socioeconomic score (p 0.24)
Count
4 11 15
18 23 41
22 34 56
< 10 ng/ml
>=10 ng/ml
25 (OH) Vitamin D
Total
< 15 >=15
Socio economic score (Modified
Kuppuswamy score)
Total
Table 11. 25(OH) Vitamin D levels with relation to bone age (p 0.3)
Count
1 14 15
7 30 3 40
8 44 3 55
<10 ng/ml
>=10 ng/ml
25 (OH) Vitamin D
Total
< 1sd Normal > 1 sd
Bone age
Total
Inference: There was no significant relation ship between 25 (OH) Vit D levels and height, 
weight, age, socioeconomic status and bone age. 
Biochemical Indices of 25(OH) Vitamin D deficiency
Figure 20 Distribution of serum Calcium levels
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The prevalence of hypocalcaemia (serum calcium <8mg/dl) was 1.8%.
Figure 21 Distribution of serum Phosphorus levels
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       Hypophosphatemia was present in 2 children (3.6%). 
   
Figure 22 Distribution of serum alkaline phosphatase levels
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All children had alkaline phosphatase levels in the normal range.
Table 12. Comparison of serum calcium, phosphorus and alkaline phosphatase levels in children 
with Vitamin D levels < 10 ng/ml and >=10 ng/ml
15 9.060 .3397 .0877
41 9.027 .5840 .0912
15 5.527 .6660 .1720
41 5.210 .7736 .1208
15 186.87 43.876 11.329
41 193.34 62.307 9.731
25 (OH) Vit D
< 10 ng / ml
>= 10 ng / ml
< 10 ng / ml
>= 10 ng / ml
< 10 ng / ml
>= 10 ng / ml
Calcium
Phosphorus
Alkaline
Phosphatase
number Mean Std. Deviation
Std. Error
Mean
 The independent samples T test was used to compare the values in the 2 groups. There was no 
statistical difference in the biochemical indices in the 2 groups The significance (2 tailed) values for 
calcium was 0.837, Phosphorus 0.166 and alkaline phosphatase 0.713. There was no significant 
difference in age and sex between the two groups. 
Bone age
Figure 23 Bone age in children with Down syndrome
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The bone age was assessed using X- Ray left hand and wrist. This was compared to Gruelich and Pyle 
standards. 55 children had bone age done.
Phenotypic Features
  
Figure 24  Phenotypic features in the children in our study    
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 The figure above shows the phenotypic features in the order of increasing prevalence.
Cardiac abnormalities
52 children had echocardiograms done. Cardiac anomalies were detected in 22 (42%).
Figure 25 Prevalence of cardiac anomaly in various age groups
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Younger children had more cardiac anomalies compared to older children (p 0.013).
Figure 26 Cardiac Anomalies on Echocardiogram vs. Weight (IAP chart)
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Figure 27 Cardiac anomalies on Echocardiogram vs. Weight (Cronk chart)
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The figures above show that children with heart disease had a lower weight centile, both on the IAP 
and Cronk charts. This was statistically significant.  (p 0.004 and 0.015)
Table 13 Correlation between clinical examination and Echocardiogram findings
Count
15 7 22
30 30
15 37 52
Abnormal
Normal
Echo
cardiogram
Total
Abnormal Normal
Cardiac clinical
examination
Total
There were 7 children who were clinically normal, but were found to have echocardiographic 
abnormalities.
There was no correlation between presence of cardiac abnormalities and the 
• sex of the child
• height of the child on the IAP and Cronk charts
• head circumference
• cytogenetic profile
• social quotient
Thyroid Abnormalities
Since thyroid abnormalities also affect growth, the thyroid function test (TFT) and thyroid stimulating 
hormone (TSH) were checked for all the children. 
Figure 28 Thyroid profile in various age groups
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The profile was as follows:
• Mild TSH elevation (TSH between 6 – 10 mU/L with normal TFT) was 16%, 
• Hypothyroidism (TSH above 10 mU/L) was 7%, 
• hyperthyroidism was 4% 
• normal thyroid function was 73%
Figure 29 Distribution of TSH values 
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The mean TSH level was 4 mU/L.
Thyroid autoantibodies
Thyroid auto antibodies were checked for the following
a. Mild TSH elevation (3 / 9 children) all negative
b. Hypothyroidism (3/4 children) all positive
c. Hyperthyroidism (2/2 children) all positive
There was no significant association between the thyroid status of the children and 
 age (p 0.24), sex (p 0.52), height as plotted on the IAP chart (p 0.94), height as plotted on the Cronk 
chart (p 0.87),  weight as plotted on the IAP chart (p 0.51), weight as plotted on the Cronk chart 
(p0.59), head circumference (p 0.62), bone age (p 0.53) and social quotient (p 0.79). 
Haematological abnormalities
Figure 30 Haematological abnormalities seen in children with Down syndrome. 
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The incidence of anaemia was 14.3%.
Atlanto-axial dislocation
Atlanto-axial dislocation was looked for in children older than 3 years as per the AAP 
recommendations. 
• 3/25 12% had evidence of atlanto-axial dislocation. 
• 2 (67%) were boys and 1 (33%) was a girl.
                                   Ophthalmologic and hearing evaluation
Of the 56 children, 41 had ophthalmologic evaluation and 40 had complete hearing assessment done. 
Ophthalmologic abnormalities were detected in 19/41 (46%) children and ENT related abnormalities 
were detected in 21/40 (53%) children.
Figure 31 Prevalence of ophthalmologic and ENT related abnormalities in children with Down 
syndrome.
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The ophthalmologic abnormalities were as follows (some children had more than one abnormality): 
refractory error 13/41 (32%), nystagmus 4/41 (10%), cataract 3/41 (7%), squint 2/41 (5%), nasolacrimal 
duct obstruction 1/41 (2.4%) and brushfield spot 1/41 (2.4%). 
ENT abnormalities: 10/40 (25%) had features of otitis media with effusion and 14/40(35 %) had 
hearing deficit either unilateral/ bilateral.
Table 14 Relationship between visual and auditory deficits (p 0.04)
5 11 16
12 6 18
17 17 34
Yes
No
Visual
defict
Total
Yes No
Auditory deficit
Total
Thirty four children had both evaluations. The interesting finding was that those who had auditory 
deficits did not have visual deficits and vice versa (p 0.04).
• Table 15 Prevalence of visual deficits in different age groups. (p 0.035)
Count
5 14 19
13 9 22
18 23 41
Yes
No
Visual
deficit
Total
<3 >=3
Age
Total
As the age increased, the prevalence of visual deficits increased (p0.035). One possibility is that 
detection of visual deficits is easier as the child grows older. Still, prevalence of 61% visual deficits in 
children over three years is very high.
Social Quotient
 55 children who were evaluated for social quotient by administering the Vineland Social Maturity 
Scale
Figure 32 Social quotient in children with Down syndrome
                The average 
social quotient was 56.
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Younger children have a larger percentage of high social quotient than older children. This was 
statistically significant (p value<0.05) 
Figure 34 Social quotient vs. the cytogenetic abnormality
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None of the children with translocation had social quotient less than 50, while 39% of the Trisomy 
and 50% of the Mosaics had low social quotient. This was not significant statistically.
Socio economic Status
Figure 35 Socio economic status of the families as per the Modified Kuppuswamy score50
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The two lower socioeconomic groups and the two upper groups were clubbed for analysis.  
Figure 36 Age of the children vs. the socio economic score
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In the less than 3 years age group, only 34.5% of the children belonged to the lower socioeconomic 
group as opposed to 44.5% in the more than 3 years age group. Children belonging to poorer 
families are brought for treatment at a later age and this can affect their overall physical and mental 
development. This was however not statistically significant.
Figure 37 Sex of the children vs. the socio economic status
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In the lower socio economic group, only 18% of the children were girls. Girls with Down syndrome 
belonging to the lower socio economic strata are not brought for treatment. 
Figure 38 Socio economic status vs. consanguineous marriages
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36% of the marriages in the lower socio economic groups are consanguineous vs. 6% in the higher 
socio economic group. This is statistically significant; p 0.004 (though one cell had an expected 
count less than 5). 
There was no statistically significant difference in 25(OH) Vitamin D levels in different SES 
groups
Discussion - Outline
• Demography
• Cytogenetic profile of children with Down
• Maternal history
• Anthropometry
• 25 (OH) Vitamin D levels
• Bone age
• Phenotypic profile
• Heart disease
• Thyroid 
• Hematology
• Ophthalmology and Hearing  
• Atlantoaxial dislocation
• Social quotient
• Socioeconomic status
Demography
56 children - 42 boys (75%), and 14 girls (25%) were included in the analysis. Thus the male: female 
ratio was 3:1. 
• In the study by Kava 11 et al, the male: female ratio was 1.37:1 and in Sachdev’s study the ratio 
was 1.84:1. 15
• In other large series abroad, the male: female ratio seen in Myrelid’s study 12 was 1.34: 1 and in 
Cronk’s study, 37 it was 1.33:1. 
Thus it is seen that our study had an unusually large number of boys. There was no statistical difference 
between the children in the different age groups with regard to their age and sex distribution. 
For analysis, the children were grouped into 2 - less than 3 years and 3 years and greater.  There were 
29 children less than 3 years and 27 children 3 years and older. 
Cytogenetic Profile
All children included in the study had cytogenetic confirmation of Down syndrome. The frequency of 
• trisomy 21 was 89.3% (50/56)
• translocation was 7.1% (4/56) 
• mosaicism was 3.6%. (2/56)
• Jyothy et al 8 analysed 1001 children. In their study, trisomy 21 was present in 87.9%, translocation in 
4.93% and mosaicism in 7.69%. 
• In Kava’s study of 221 patients, trisomy 21 was present in 95%, translocation in 3.2% and mosaicism 
in 1.8%. 11
• Sheth et al 10 analysed 382 children and found free trisomy 21 constituted 84.8% of cases, translocation 
8.9%, mosaic 3.9% and in 2.4% cases regular T21 was associated with structural or numerical changes.  
Translocation
3 children in the study had t (21; 21) translocation and one had t (14; 21). 
This is similar to the data presented by Sheth 10 in which the homologous translocation (21q21q) is one 
of the most common chromosomal rearrangements in DS.
Maternal History
Maternal age at delivery
• 11% of the mothers were older then 35 years. In Verma’s series, 33% of the mothers of 
children with Down syndrome were over 35 years. 39
• The mean age was 26.75 years with standard deviation of 5.67 years. This is very similar to the 
mean age of 26.8 years in the study by Kava. 11
Previous spontaneous abortions
Five (9.1%) of the mothers had previous spontaneous abortions. Hook EB stated that “the younger the 
mother and the more the number of abortions, the higher the relative risk of a Down syndrome live 
birth.” 40
Maternal grandmother’s age
In our study, the mean age of the maternal grandmother at time of mother’s birth was 24 years. 
(However some of the parents were not sure about the exact age). Malini et al 41 suggested that 
increased maternal grandmother’s age at the time of mother’s birth was a risk factor for Down 
syndrome. For every year of advancement of age of the maternal grandmother, the risk (odds) of birth 
of DS baby increases by 30%.
Grandparents consanguineously married
8 of the 55 children ie 15%, (1 child excluded as the child was adopted), had consanguineously married 
grand parents. Sayee et al found the incidence of grandparental and parental consanguinity to be 17.5%. 
They however concluded that consanguineous marriage did not predispose to Down syndrome. 42
Parents consanguineously married
10 (18%) of the 55 children had consanguineously married parents. In Sayee’s study, 42 the incidence of 
parental consanguinity was 17.2 %.
Antenatal detection of Down Syndrome
Antenatal scan was done in 39 (69.6%) of the 55 children. In none of the scans were features of Down 
syndrome picked up. None of the mothers underwent any screening for Down syndrome. None of them 
knew antenatally that their child had Down syndrome.
This was in contrast to other countries where second trimester screening for Down's syndrome is 
widely practiced. 43, 44
Birth rank of the children
23 of the children were the first born, 28 were second/ third born, and 4 children were of the birth rank 
4 or greater. 1 child was adopted and details were not known.
Mean birth weight
The mean birth weight of the children was 2.5kg. The minimum weight was 1.4kg and the maximum 
weight was 3.92kg. This corresponds to the study by Sachdev who stated that average birth weight 
varies from 0.5-1 SD below the control means.  As per the figures depicted in their study, the 50th 
centile was approx. 3kg. 15
Anthropometry
Growth monitoring is a screening tool to diagnose nutritional, chronic systemic and endocrine disease 
at an early age. Unfortunately, there are no growth charts for Indian children with Down syndrome. So, 
the height and weight of each child was plotted on the IAP growth charts and growth charts by Cronk 
for Children with Down syndrome. Head circumference for children less than 3 years was plotted on 
the IAP chart.
Height
The Kappa was estimated in order to evaluate agreement between the classifications of height for age 
according to the two charts. The kappa value was -0.120. Thus, there was poor agreement among the 
two charts
Weight
Children with Down syndrome are usually overweight. However in our study, at least three fourths of 
the children were below the 50th percentile – irrespective of the growth chart used. The Kappa value 
between the two charts was 0.325. Thus, here too, there was poor agreement among the two charts
Head Circumference (age <3 years)
The head circumference was plotted on IAP growth charts for children less than 3 years. 86% of them 
were microcephalic (<3rd centile). This corresponds to the study by Sachdev15 where all children had 
head circumference below the 10th centile.
Height Vs Age
The children were clubbed into 2 groups based on their age (< 3years and >=3 years). There was no 
statistical difference between the children in the two age groups with relation to their height – (IAP and 
Cronk charts).
Weight Vs Age
There was no difference between the age groups when the Cronk charts were used to plot weight. 
However, when the IAP chart was used, it was found that 90% of the children less than 3 years were 
below the 25th percentile as opposed to 56% of those above three years. This was statistically 
significant (p 0.004). Thus children with Down syndrome appear to increase their weight with age 
(table 3). Styles et al found that there was a high prevalence of overweight/obesity, particularly in 
adolescence and adult life. 3
25(OH) Vitamin D levels
Pettifor in an editorial in Indian Pediatrics recommended a cut off value of 10 ng/ml to define vitamin 
D deficiency.  19  In  our  study,  26.8% of  children  had  25 (OH) Vitamin  D levels  below 10 ng/ml. 
Unfortunately there is a paucity of literature on the prevalence of Vitamin D deficiency in the general 
population in India. 
• Tiwari et al 45 found the prevalence of hypovitaminosis (< 14 ng / ml) in Delhi in certain slums 
in children aged 9 months to 30 months to be 83%. However in other slums, prevalence was 
only 2%. 
• Harinarayan et al  46  defined Vitamin D deficiency to be less than 20 ng / ml and found the 
prevalence in children to be between 63 and 82% in different populations in Andhra Pradesh.
• Marwaha et al saw hypovitaminosis D (< 9 ng/ml) in 36% of children. 18
The demography of vitamin D deficiency
The prevalence of low vitamin D level is more in children less than 3 years (p0.051). This is probably 
because of low exposure to sunlight in this age group.
There was no statistically significant difference between the following parameters among the groups 
with vitamin D levels less than 10 ng / ml and those more than that.
• Sex of the child (p 0.6)
• Height as plotted on the IAP chart (p 0.75)
• Height as plotted on the Cronk chart (p 0.26)
• Weight as plotted on the IAP chart (p 0.95)
• Weight as plotted on the Cronk Chart) (p 0.41)
• Socio economic score (p 0.24)
Only one study (Del Arco et al in 1992) published their findings from 21 children with Down 
syndrome in Cantabria, Spain.  The average values of the three Vitamin D metabolites were 
comparable to those of an age-matched group both in winter and summer. No child with DS showed 
values below the normal range, either in Vitamin D metabolites, or in the other parameters of calcium 
metabolism. They suggested that these children do not require Vitamin D when appropriate sunlight 
exposure is provided. Our study also shows that Vitamin D deficiency is not associated with delay in 
growth. 5
25(OH) Vitamin D levels with relation to bone age
Bone age is the average age at which children reach a particular age of bone maturity.
It corresponds to the age of the child in normal children. 
• In our study, 55 children had X-rays of the left hand and wrist done. The bones in the X-ray 
were compared to the Greulich and Pyle standard by a Radiologist. 22 The bone age was noted 
and features of rickets were looked for. 
• There was no statistically significant difference in the bone age between the groups with 
25(OH) vitamin D levels below and above 10 ng/ml (p= 0.3).
• There was one X-ray suspicious of rickets (X-ray reported as mild fraying of the distal ulnar 
and radial metasphyses - could be artefactual in view of suboptimal positioning). This child’s 
25(OH) vitamin D level was 21.5, with normal serum calcium, phosphorus and vitamin D 
levels). Otherwise, there were no radiological features suggestive of rickets.
Biochemical Indices of Hypovitaminosis D
• The prevalence of hypocalcemia (serum calcium less than 8mg/dl) was 1.8%. 
• Hypophosphatemia was present in 2 children (3.6%). 
• All children had alkaline phosphatase levels in the normal range.
Comparison of serum calcium, phosphorus and alkaline phosphatase levels in children with 
Vitamin D levels < 10 ng/ml and >=10 ng/ml
One of our aims was to see if children with low levels of Vitamin D had concomitant decrease in serum 
calcium and phosphorus and an increase in alkaline phosphatase levels. We divided the children into 2 
groups – Vitamin D less than 10 ng/ml and >= 10 ng/ml. The following table gives the values in the 2 
groups.
The independent samples T test was used to compare the values in the 2 groups. There was no 
statistical difference in the biochemical indices in the 2 groups. The significance (2 tailed) values for 
calcium was 0.837, Phosphorus 0.166 and alkaline phosphatase 0.713. There was no significant 
difference in age and sex between the two groups. 
This is similar to the findings of Del Arco et al. 5
Bone age
The bone age is an independent tool to assess the growth of a child irrespective of the anthropometric 
measures such as height and weight. The bone age was assessed using X-Ray left hand and wrist. This 
was compared to Gruelich and Pyle standards. 22
55 children had bone age done. 
• 80% were appropriate for age.
• In 15% bone age was delayed. 
• In 5% bone age was advanced.
The bone age was significantly related to the weight of the child on both the IAP and Cronk charts with 
children with lower weights having delayed bone age. However, because of the small numbers, there 
were many cells with expected value less than 5 and so this has to be cautiously interpreted.
There was no correlation between the bone age and the 
• age of the child
• sex
• height,
• head circumference
• cytogenetic profile
• Serum Vitamin D
• atlanto-axial dislocation
• socioeconomic score.
Phenotypic Features
Children with Down syndrome have characteristic phenotypic features. In our study, their prevalence 
was as follows:
• hypertelorism (3.6%)
• epicanthal folds (64.3%)
• upslanting eyes (98.2%)
• malformed ears( 26.8%)
• flat facies (96.4%)
• simian crease (50%)
• clinodactyly (69.6%)
• sandal gap (50%)
Kava et al in their retrospective analysis noted mongoloid slant in 83.9%, ear abnormalities in 66.9%, 
epicanthic folds in 56.9%, and flat facial profile in50.9%, simian crease in 33.2%, clinodactyly in 36.1% 
and sandle sign in 46.2%. 11
               
Cardiac abnormalities
52 children had echocardiograms done, cardiac anomalies were detected in 22 (42%) of them. This was 
similar to the data submitted by Bhatia et al (44%). 24
The echocardiogram anomalies were 
• 9/22 (40.9%) had atrial septal defects
• 8/22 (36.4%) had ventricular septal defects
• 6/22 (27.3%) had patent ductus arteriosus
• 2/22 (9.1%) had atrio-ventricular canal defects
• 2/22 (9.1%) had other defects- mitral valve and tricuspid valve prolapse; Pulmonary 
regurgitation with pericardial effusion 
Younger children had more cardiac anomalies compared to older children. This was statistically 
significant. (p 0.013)
Kava et al 11conducted a retrospective study on 524 patients over 7.5 years. Congenital heart disease was 
clinically diagnosed in 96 cases (18.3%). The nature of the cardiac defect was ascertained by color 
Doppler examination and/or 2D-echocardiography in 58 cases. The most common cardiac anomalies 
were ventricular septal defect (25.8%), tetralogy of Fallot (15.5%), and atrial septal defect (12.1%). 
Bhatia et al 24 evaluated the utility of echocardiography in assessing the frequency and nature of cardiac 
malformations in children with Down syndrome. Fifty cases of chromosomally proven Down 
syndrome were studied.  Endocardial-cushion-defect was the commonest anomaly, followed by 
ventricular septal defect.
Thyroid Abnormalities
Since thyroid abnormalities also affect growth, the thyroid function test (TFT) and thyroid stimulating 
hormone were checked for all the children. 
In our study, the profile was as follows:
• Mild TSH elevation (TSH between 6 – 10 mU/L with normal TFT) was 16%, 
• Hypothyroidism (TSH above 10 mU/L) was 7%, 
• hyperthyroidism was 4% 
• normal thyroid function was 73%
This fits in with literature where there is a wide variation in prevalence of hypothyroidism from 3 – 
54% depending on the definition used. 47
                                       
Thyroid autoantibodies
Thyroid auto antibodies were checked for the following
a. Mild TSH elevation (3 / 9 children) all negative
b. Hypothyroidism (3/4 children) all positive
c. Hyperthyroidism (2/2 children) all positive
Thus it is worthwhile checking thyroid antibody status for all children with hypo and hyperthyroidism.
In a five year longitudinal study of 101 children with Down syndrome, Selikowitz found no differences 
in growth and development between those with slightly raised TSH, showing compensated 
hypothyroidism, and those with normal TSH. 48
 
There was no significant association between the thyroid status of the children and 
• Age (p 0.24) and sex (p 0.52)
• Height as plotted on the IAP chart (p 0.94)
• Height as plotted on the Cronk chart (p 0.87)
• Weight as plotted on the IAP chart (p 0.51)
• Weight as plotted on the Cronk chart (p0.59)
• Head circumference (p 0.62)
• Bone age (p 0.53)
• Social quotient (p 0.79) 
Haematological abnormalities
  
• Anemia was detected in 8 (14%) of the children.
•  Pre B ALL was identified in 3 (5.4%) of the children.
• Thrombocytopenia defined as platelet count less than 100 000/mm3 was detected in 4 (7.1%) of 
the children.
• Thrombocytosis as defined as platelet count > 450 000 was detected in 3 (5.4%) of the children.
Awasthi et al studied a total of 239 cases of Down syndrome of which of 15 had hematological 
manifestations at presentation. These comprised 4 cases of transient myeloproliferative disorder, 3 
cases of TMD/acute leukemia, 4 cases of acute leukemia (AL), 2 of dual deficiency anemia, and 1 case 
each of myelofibrosis and idiopathic thrombocytopenia. 49
The incidence of Pre B ALL in our study is probably higher as we are a tertiary care centre with a well 
set up Pediatric Oncology Department.
                                  Ophthalmologic and hearing evaluation
Of the 56 children, 41 had ophthalmologic evaluation and 40 had complete hearing assessment done. 
Ophthalmologic abnormalities were detected in 19/41 (46%) children and hearing abnormalities were 
detected in 21/40 (53%) children.
The ophthalmologic abnormalities were as follows (some children had more than one abnormality):
• refractory error 13/41 (32%)
• nystagmus 4/41 (10%)
• cataract 3/41 (7%)
• squint 2/41 (5%)
• nasolacrimal duct obstruction 1/41 (2.4%)
• brushfield spot 1/41 (2.4%) 
As the age increased, the prevalence of visual deficits increased (p0.035). One possibility is that 
detection of visual deficits is easier as the child grows older. Roizen 1concluded that ophthalmologic 
disorders are found in about 38% of children less than 12 months, and 80% of those between 5 -12 
years. The most frequent disorders found in children are refractive errors (35-76%), strabismus 
(27-57%), and nystagmus (20%).
Another interesting finding was that visual abnormalities were commoner in those who were below the 
25th percentile in weight as per the IAP charts and it was opposite for those who were above the 25th 
percentile (p0.02).
47 children were evaluated for hearing abnormalities. Out of these, 7 children went to ENT outpatient 
clinic, but did not complete their evaluation and so were excluded. 21 of the remaining had abnormal 
findings. Roizen 1 stated hearing loss to be between 38 – 78%.
10/40 (25%) had features of otitis media with effusion
14/40(35 %) had hearing deficit either unilateral/ bilateral. 
Thirty four children had both ENT and ophthalmological evaluations. The interesting finding was that 
those who had auditory deficits did not have visual deficits and vice versa. This was statistically 
significant (p 0.04)
Atlantoaxial dislocation and Down syndrome
Atlantoaxial dislocation was looked for in children older than 3 years as per the AAP 
recommendations. 3/25 (12%) had evidence of atlantoaxial dislocation. 2 were boys and 1 was a girl. 
One of the children had surgical stabilization of the spine.
This is similar to the data by Pueschel et al who reported that 14.6% of 404 patients with
Down syndrome had an Atlanto Dens interval greater than 4.5 mm, but only 1.5% of the group had 
symptoms and was ultimately treated with surgical stabilization of the cervical spine. 33
Social Quotient
Out of the 55 children who were evaluated for social quotient by administering the Vineland Social 
Maturity Scale
• 40% had a social quotient of 50-69
• 24% had a social quotient >= 70
• 22% had a social quotient of 35- 49
• 2% had social quotient of <35
The average social quotient was 56.
In the study by Bhatia, 34 out of the 22 children whose Developmental Quotient was evaluated by 
administering Gessel’s developmental schedule, Seguin Form board, Vineland Scoial Maturity Scale, 
DASSI- II ( Bayley’s scale), Malin’s Intelligence Scale (for Indian children) and Stanford- Binet test - 
50% had a DQ between 51- 70.
Social quotient vs. age
Younger children have a larger percentage of high social quotient than older children. This was 
statistically significant (p value<0.05) 
This implies that with early developmental assessments and intervention, the social quotient of older 
children can also be improved. Another explanation is that the VSMS administration is more suited to 
older children than younger ones.
None of the children with translocation had social quotient less than 50, while 39% of the Trisomy and 
50% of the Mosaics had low social quotient. This was not statistically significant.
Socio economic Status
The modified Kuppuswamy score was used to assess the socio economic status of the family. It has 
three components – family income, education and occupation. The majority of parents in our study 
belonged to the upper middle class followed by the upper lower class. 50
 
The two lower socioeconomic groups and the two upper groups were clubbed together for analysis. 
Thus the lower socio economic group had 22 (39%) children and the upper socioeconomic group had 
34 (61%) children. Children from families belonging to the lower socioeconomic group are brought 
later for treatment.
There was no statistically significant difference in 25(OH) Vitamin D levels in different SES groups. 
This is contrary to  Marwaha et al 18 in their study on normal Indian children  found that children of 
LSES had more vitamin D deficiency (42.3% using a cutoff as < 9ng/ml) as compared to USES group 
(27%)
                                                       
                                                            Summary
A prospective descriptive study was conducted in the Department of Child Health, Christian Medical College, 
Vellore – a tertiary care medical centre in South India from October 2007 to September 2008. The aims were 
to:
3. Study the prevalence of Vitamin D deficiency by assessing 25(OH) Vitamin D levels in children with 
Down syndrome.
4. Assess the effect of Vitamin D deficiency on height, bone age and other biochemical markers in these 
children. 
3.  Assessment of the phenotypic and cytogenetic profile of children with Down syndrome and presence of 
common associated malformations, deficiencies and associated illnesses.
4.  An evaluation of their social quotient.
a. 56 cytogenetically proven Down syndrome were enrolled in the study.
b. Frequency of regular trisomy was 89.3%, translocation was 7.1% and mosaicism was 3.6%
c. Prevalence of 25(OH)vitamin D deficiency using a cut off value of 10ng/ml was 26.8%
d. There was no significant effect of vitamin D deficiency on height, bone age or other associated biochemical 
markers
e. The prevalence of phenotypic features was as follows:  hypertelorism (3.6%), epicanthal folds (64.3%), upslanting 
eyes (98.2%), malformed ears (26.8%), flat facies (96.4%), simian crease (50%), clinodactyly (69.6%) and sandal 
gap (50%).
        Prevalence of 
Mild TSH elevation 16%
Hypothyroidism 7%
Hyperthyroidism 4%
        Ophthalmologic abnormalities were detected in 46% and ENT related abnormalities in 53%.
        Pre B Acute lymphoblastic leukaemia was identified in 5.4% of the children.
         Cardiac anomalies were detected in 42%. The common cardiac abnormalities were atrial septal defect, 
ventricular septal defect and patent ductus arteriosus.
        12% (3/25) had evidence of atlanto-axial dislocation.
          64% of children had social quotient <70.
Conclusions
         1.The prevalence of 25(OH) Vitamin D deficiency in children with Down syndrome was 26.8%.
        2.  There was no significant effect of 25(OH) Vitamin D deficiency in the height, bone age and other  
biochemical markers in these children.
                                             
      Limitations of the study
• The population prevalence of vitamin D deficiency in children in India is unknown.
• Various studies have used different cutoff values for vitamin D deficiency and insufficiency.
• There were no age and sex matched controls of normal children for the 25(OH) vitamin D 
levels, anthropometric measurements, biochemical indices etc.
• There are no standard Indian Down syndrome charts for reference.
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Annexure 1. Steps of Peripheral blood karyotyping for Down syndrome
1. Setting up: 
i. Check the hospital number on the form, tube and enter into the register
ii. Check whether the sample has a clot in it as this may interfere with the result.
iii. Prewarm the media- RPMI 1640(Ros Well Park Memorial Institute 1640). 
iv. Use 2 tubes for each patient- label them A and B
v. Incubate the tubes with the media at 37C for 15 mins.
vi. PHA(Phytohemagglutinin) is taken from the fridge and allowed to thaw. The PHA is a 
mitogen, and it stimulates the division of T cells
vii. To 5ml of prewarmed media, add 300 microlitres of PHA and then the blood sample as per 
age(mentioned below).
viii. Keep in the incubator. Daily mix the sample. Harvesting is done from 69-72 hours.
Age                                                                Sample of blood to be taken
3months- 6months                                         250microlitres to one tube
                                                                       300microlitres to second tube
6months- 10months                                       250microlitres to one tube
                                                                       500microlitres to second tube
1-3 years                                                        500microlitres to one tube
                                                                       300microlitres to second tube
4 years onwards                                             500microlitres to both tubes
                                                                      
2. Harvesting: There are 3 steps- mitotic arrest, hypotonic treatment and fixation.
i. To the sample at 69 hours, colcemid is added (this arrests cells in metaphase). This is 
incubated for 1 hour.
ii. The sample is centrifuged for 10 minutes. After the spinning is over, the supernatant is 
discarded.
iii. To the pellet at the bottom of the tube, potassium chloride is added along the sides of the 
tube- drop by drop, tapping gently, upto the 10ml mark. This is kept in a water bath for 
incubation at 37C for 10 minutes. This causes cell swelling and the chromosomes to spread 
out.( Hypotonic treatment)
iv. 10 minutes later, prefix the tubes with fixative- methanol: acetic acid (3:1); add 10 drops to 
each tube. (Acetic acid lyses the RBCs and Methanol hardens the cell wall so that it will not 
break.).
v. Centrifuge again for 10 minutes.
vi. A brown pellet is formed at the bottom of the tube. The supernatant is discarded. The pellet 
is washed twice with 1ml of fixative (added drop by drop) for 1 minute. The supernatant is 
drained. Tap the tube and then add 10ml of fixative gradually.
3. Making the tube ready for slide making:
Freeze the above tube for 20 minutes.
Take the tube out to thaw at room temperature for 15 minutes.
Centrifuge for 10 minutes. Discard the supernatant.
Add 5ml of fixative again and centrifuge it. Remove the supernatant. 
A white pellet is obtained at the bottom of the tube.
4. Slide making:
Optimal Conditions for slide making
      Optimal temperature of the room: 20-22C
Relative Humidity                       : 50- 60%
Angle of slide                              : 20-30
Drying seconds                             : 35-40 sec
Aging time                                   : 90-96C for 20 minutes
Warmer temperature                    : 37C
Nature of water                            : Deiodinised distilled water- chilled water
Method of slide cleaning- Soak the slide in methanol. Wipe dry. Resoak in methanol. Rotate the 
slides in cold water, and when the slides are taken out, a thin film of water is seen. 
Stir the white pellet with fixative at a temperature of 20-22C, humidity of 50-60%.
Add one drop of the solution to the prepared slide at an angle of 20-30. Wipe the back of the slide 
and the sides.
Let the slide dry for 35-40 sec on a warmer (temp 37C)
Label the slide after it is dry.
View under a Phase Contrast Microscope to see the metaphases. A good metaphase is thin, long, 
well spread with minimal overlaps and is non refractile. 
Keep the slide in an oven at 90- 96C for 20 mins. The slide is now ready for banding.
5. Banding: 
Trypsin is prewarmed for 15 minutes. Dip the slides in trypsin. Slides on day 1 are dipped for 10-12 
sec, 2 seconds added for each subsequent day. 
Trypsin denatures the chromosomes so that the dark and light bands can be differentiated. 
The slides are washed in ice cold saline, then Leishmann stain is added. The slide is stained for 2 
minutes. The stain is washed off with cold tap water. The slide is dried and viewed under a 
microscope. The metaphases appear spread out and clearly seen.
6.  Capturing and Analysis  :
The slide is viewed under a microscope. The Ikaros software (Multisystem Germany) is used to 
separate out the chromosomes. A minimum of 20 metaphases are studied. 
Karyotypes are described according to ISCN 2005- International System for Human Cytogenetic 
Nomenclature 2005 by Shaffer LG, Tommerup N., as per the Recommendation of International 
Standing Committee of Human Cytogenetic Nomenclature, Published by Cytogenetic and Genome 
Research, by Karger S. and Basel 2005.
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            Growth and cytogenetic profile and vitamin D levels in children with Down syndrome
Information sheet
             You are being requested to participate in a study to see if children with Down syndrome have reduced Vitamin D 
levels.  We hope to include about 40 children from this hospital in the study. 
 
           What is Down syndrome?
              Down's syndrome is caused by the presence of an extra chromosome - one of the tiny bundles of DNA found in all of 
our cells. Normally we have 46 chromosomes in every cell in our body, 23 from each of our parents. In Down's 
syndrome, an extra copy of chromosome number 21 is included. The baby will have 47 chromosomes in each body. 
The extra chromosome causes characteristic physical features, usually including slanting eyes, a flat face, a large
 tongue and broad hands with little fingers that curve inwards. Further information on this syndrome is available at 
http://www.downs-syndrome.org.uk/  
Why is this study being conducted?
Children with Down syndrome are short. The cause for this is not clear. Other children (children without Down’s syndrome) 
with reduced Vitamin D levels are also short. We want to see if this growth retardation in children with Down syndrome is 
because of reduced Vitamin D levels.
If you take part what will you have to do? 
You will be asked questions regarding the child and his parents. The child will be examined in detail which will include an ear, 
eye and heart check up. In addition to the usual blood tests, 1-2 ml of blood will be taken for this study to check the Vitamin D 
levels and related body elements and enzymes. You will not receive any remuneration if you decide to participate in the study.
Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to decide to withdraw permission to participate in 
this study. If you do so, this will not affect your usual treatment at this hospital in any way. 
 
Will we get the results of this blood test?
The results of the blood tests will be available and you can receive a copy of the values.
What happens if there is an abnormality in the blood tests? 
If there is a deficiency in the Vitamin D levels, the child will be given appropriate treatment.
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal. You will not be identified by name in any publication or 
presentation of results. Your medical notes will be reviewed by people associated with the study.
If you have any further questions, please ask Dr. Anila Chacko (tel: ******    or email: ******)
CONSENT TO TAKE PART IN A CLINICAL STUDY
 
Title:  Growth and cytogenetic profile and vitamin D levels in children with Down syndrome
 
Study Number: 
 
Participant’s name:  
 
Date of Birth / Age (in years): 
 
I________________________, son/daughter of ________________________________, 
Relationship with the patient ___________________________________
(Please tick boxes) 
 
• Declare that I have read the information sheet provide to me regarding this study and have clarified 
any doubts that I had. [ ] 
 
• I also understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting my usual treatment or 
my legal rights [ ] 
 
• I understand that the study staff and institutional ethics committee will not need my permission to 
look at my health records even if I withdraw from the trial. I agree to this access [ ]  
 
• I understand that my identity will not be revealed in any information released to third parties or 
published [ ] 
 
• I voluntarily agree to take part in this study [ ] 
 
Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
 
 
 Clinical profile of patients presenting with Down syndrome
1. Name:                              2. Hospital No:                 3. Date of examination:               4.Case No.
5. Date of birth:                    6. Age: 7. Sex: (i) boy (ii) girl    
8. Birth rank (including abortions and stillbirths and deaths): (i) 1 (ii) 2 (iii) 3 (iv) >= 4 
9. Previous abortions: (i) Yes (ii) No
10. Permanent family planning measures: (i)Tubal ligation (ii) vasectomy (iii) hysterectomy 
11. Mid parental height 
12. Maternal grandmother age at time of mother’s birth:                   Sure of age yes /no
13. Any of the grandparents consanguineously married? (i) Yes (ii) No
14. Relatives/Siblings / parents with Down syndrome: (i) Yes (ii) No 
 
15. Consanguineous marriage: (i) Yes (ii) No           
16.a. Antenatal scan done: (i) Yes (ii) No b.Any abnormality detected: (i) Yes (ii) No
If yes, what?    
 
17. Down syndrome detected antenatally? (i) Yes (ii) No
Antenatal tests- Maternal serum alfafetoprotein, 
                           HCG, 
                          Oestradiol
                          Amniocentesis
                         Chorionic villus biopsy
18. Maternal age at the time of birth:   Sure of maternal age yes /no         
19. Cried immediately at birth (i) yes (ii) No             20. Birth weight:          (TermGA/Preterm GA)
21. Height cm:           centile                                       22. Weight kg:          centile
23. Head circumference:            (i) Normal (ii) Microcephaly (iii) Macrocephaly
24. Face (i) Hypertelorism : Inner canthal: Outer canthal ratio
            (ii)Flat facial profile                    (i) Yes (ii) No
            (iii)Upslanting palpebral fissure (i) Yes (ii) No
            (iv)Epicanthal folds                    (i) Yes (ii) No                
(v)Prominent malformed ears     (i) Yes (ii) No
25. Hands and feet: Simian crease (i) Yes (ii) No
                          Short broad hands (i) Yes (ii) No
                          Clinodactyly         (i) Yes (ii) No
                          Sandle gap            (i) Yes (ii) No
                          
26. Cardiovascular findings:
27. Ophthalmology findings:
28. Hearing levels:
29. Social Quotient:
30. Hall’s Criteria for principal features in newborn:
1. Hypotona
2. Poor Moro reflex
3. Hyperflexibility of joints
4. Excessive skin on back of neck
5. Flat facial profile
6. Slanted palpebral fissure
7. Anomalous auricles
8. Dysplasia of pelvis
9. Dysplasia of midphalanx of 5th finger
10. Simian crease 
31. Complete blood count (i) Anemia/ (ii) thrombocytopenia/ (iii) Polycythemia/
(iv) Evidence of malignancy/ (v) No evidence of malignancy
32. Serum Calcium level   __________    (i) Normal (>7mg/dl) (ii) Abnormal (<7mg/dl)
33. Serum Phosphorus level ___________
34.25(OH) Vitamin D level ___________      Normal (25(OH) Vitamin D 9- 37.6 ng/ml
35. Thyroid function tests (i) Normal/ (ii) Abnormal
36. ECHO:
37. Xray C Spine for children older than 3 years:
37. Xray left hand and wrist for bone age/ rickets:
38. Cytogenetics? Yes/ no                                           Cytogenetic analysis: 
SES (Modified Kuppuswamy score)
(A)Education
1. Professional or honours 7
2. Graduate or post graduate 6
3. Intermediate or post high school diploma 5
4. High school certificate 4
5. Middle school certificate 3
6. Primary school or literate 2
7. Illiterate 1
(B)Occupation
1. Profession 10
2. Semiprofession 6
3. Clerical, shop owner or farmer 5
4. Skilled worker 4
5. Semi skilled worker 3
6. Unskilled worker 2
7. Unemployed 1
(C)Family income per month (Rounded off to the nearest 50)
1. >/13500                                                                   12
2. 6750-13499                                                             10
3. 5050-6749                                                                6
4. 3375-5049                                                                4
5. 2025-3374                                                                3
6. 676-2024                                                                  2
7. <- 675                                                                       1
Total Score                                          Socioeconomic class   
  26-29                                                 Upper (I)
  15-25                Middle                      Upper Middle (II)
  11-15                                                 Lower Middle (III)
   5-10                 Lower                       Upper Lower (IV)
   <5                                                      Lower
